ESSA Pharma Inc (EPIX) — Cash Flow-to-Debt Ratio
ESSA Pharma Inc (EPIX) has a Cash Flow-to-Debt Ratio of -2.63x as of June 2025, meaning its operating cash flow of $-4.20 Million could theoretically repay -3% of its total liabilities ($1.60 Million) in one year. See free cash flow generation of ESSA Pharma Inc to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
ESSA Pharma Inc Cash Flow-to-Debt Ratio (2012–2024)
Historical debt coverage capacity for ESSA Pharma Inc across 13 annual periods. Also explore ESSA Pharma Inc annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for ESSA Pharma Inc (2012–2024)
Year-by-year debt coverage analysis for ESSA Pharma Inc. For market capitalisation and broader financial context, see ESSA Pharma Inc market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | -6.48x | $-22.72 Million | $3.51 Million | ▼ -14.5% |
| 2023 | -5.66x | $-19.78 Million | $3.50 Million | ▲ +52.9% |
| 2022 | -12.03x | $-28.70 Million | $2.39 Million | ▼ -96.8% |
| 2021 | -6.11x | $-25.42 Million | $4.16 Million | ▲ +52.1% |
| 2020 | -12.76x | $-16.98 Million | $1.33 Million | ▼ -482.6% |
| 2019 | -2.19x | $-12.25 Million | $5.59 Million | ▼ -47.2% |
| 2018 | -1.49x | $-10.22 Million | $6.87 Million | ▲ +15.3% |
| 2017 | -1.76x | $-17.35 Million | $9.88 Million | ▼ -25.6% |
| 2016 | -1.40x | $-15.30 Million | $10.94 Million | ▲ +65.1% |
| 2015 | -4.01x | $-12.30 Million | $3.07 Million | ▼ -329.5% |
| 2014 | -0.93x | $-2.08 Million | $2.23 Million | ▼ -21848.8% |
| 2013 | 0.00x | $-763.35 | $179.34K | ▲ +100.0% |
| 2012 | -13.71x | $-1.82K | $133.04 | — |